Literature DB >> 22495894

An immunologic basis for placental insufficiency in fetal growth restriction.

Laura G Greer1, Mandolin S Ziadie, Brian M Casey, Beverly B Rogers, Donald D McIntire, Kenneth J Leveno.   

Abstract

OBJECTIVE: We sought to determine whether chronic villitis, an immunologic disease of the placenta, was related to fetal growth restriction.
METHODS: Beginning in October 1999, a protocol was instituted that required placentas of high-risk births be submitted for standardized histological examination. Chronic villitis was diagnosed when a lymphohistiocytic infiltrate involving placental villi was present and was graded according to the extent and location of the infiltrate. Fetal growth restriction was defined as weight less than 3rd, 5th, and 10th percentiles. Placental hypoplasia was defined as weight less than 10th percentile.
RESULTS: In the 10,204 placental examinations that were performed, low-grade and high-grade chronic villitis was associated with hypoplastic placentas and fetal growth restriction. Infants with placentas with low-grade and high-grade chronic villitis were more likely to require cesarean delivery for nonreassuring fetal heart rate compared with controls (27% and 25% versus 21%; p < 0.05). Fetal acidemia (umbilical artery pH < 7.0) was associated with high-grade chronic villitis compared with controls (4% versus 2%; p < 0.05).
CONCLUSION: Chronic villitis was associated with anatomic and functional placental insufficiency manifested as placental hypoplasia, growth restriction, increased risk of cesarean for nonreassuring fetal heart rate, and fetal acidemia. These findings support an immunologic basis for fetal growth restriction.
Copyright © 2012 by Thieme Medical Publishers

Entities:  

Mesh:

Year:  2012        PMID: 22495894     DOI: 10.1055/s-0032-1310525

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  7 in total

1.  Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.

Authors:  C Janzen; M Y Y Lei; J Cho; P Sullivan; B-C Shin; S U Devaskar
Journal:  Placenta       Date:  2013-08-28       Impact factor: 3.481

2.  Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity.

Authors:  Jessica Saben; Ying Zhong; Horacio Gomez-Acevedo; Keshari M Thakali; Sarah J Borengasser; Aline Andres; Kartik Shankar
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-30       Impact factor: 4.310

Review 3.  Placental origins of neonatal diseases: toward a precision medicine approach.

Authors:  Imran N Mir; Rachel Leon; Lina F Chalak
Journal:  Pediatr Res       Date:  2020-12-07       Impact factor: 3.756

4.  Impact of multiple placental pathologies on neonatal death, bronchopulmonary dysplasia, and neurodevelopmental impairment in preterm infants.

Authors:  Imran N Mir; Lina F Chalak; L Steven Brown; Sarah Johnson-Welch; Roy Heyne; Charles R Rosenfeld; Vishal S Kapadia
Journal:  Pediatr Res       Date:  2019-12-07       Impact factor: 3.756

5.  Nicotine protects fetus against LPS-induced fetal growth restriction through ameliorating placental inflammation and vascular development in late pregnancy in rats.

Authors:  Junjie Bao; Yong Zou; Yuanyuan Liu; Li Yuan; Robert E Garfield; Huishu Liu
Journal:  Biosci Rep       Date:  2019-07-02       Impact factor: 3.840

6.  Autism spectrum disorders in extremely preterm infants and placental pathology findings: a matched case-control study.

Authors:  Imran N Mir; Stormi P White; L Steven Brown; Roy Heyne; Charles R Rosenfeld; Lina F Chalak
Journal:  Pediatr Res       Date:  2020-09-19       Impact factor: 3.756

7.  High rate of chronic villitis in placentas of pregnancies complicated by influenza A/H1N1 infection.

Authors:  Wouter J Meijer; Annemarie M J Wensing; Hein W Bruinse; Peter G J Nikkels
Journal:  Infect Dis Obstet Gynecol       Date:  2014-02-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.